CDSCO SUGAM Portal SAE Reporting User Manual

This is a guideline for reporting serious adverse events of medicines.


CDSCO SUGAM Portal SAE Reporting User Manual - cover page
Brand
CDSCO
Category
Healthcare software
Document type
User Manual
Language
English
Pages
58
File format
PDF
File size
4.5 MB
Published
03 November, 2023
Updated
03 November, 2023
MD5 checksum
EE666AA8A009B7541B00B990E275B1CD

About this manual

This manual provides step-by-step instructions for reporting serious adverse events (SAEs) on the SUGAM portal, the Central Drugs Standard Control Organization's online system for clinical trial management in India. It defines SAE criteria, outlines reporting timeframes (24 hours, 14 days, 30 days), identifies responsible parties (investigators, sponsors, ethics committees), and details the process flow from site investigator registration through SAE submission.

The document covers both online reporting via SUGAM and offline reporting for clinical trials not registered on the portal. It includes procedures for adding and mapping site investigators, initiating clinical trials, submitting various SAE report types, and using the E-Vartalaap communication module for follow-up reports. Screenshots and form illustrations guide users through each portal screen.

What's inside

  • Serious Adverse Events
  • What is a Serious Adverse Event
  • General SAE Reporting Policy
  • Timeframe for initial SAE reports submission
  • Recipients of SAEs reports
  • Process Flow for SAEs Reporting
  • SAE Reporting (24 Hours)
  • SAE Reporting (14th Day due Analysis Report)
  • SAE Reporting (14th Day Report by Sponsor)
  • SAE Reporting (30th Day Report)

Specifications

Version1.0
Issuing OrganizationCentral Drugs Standard Control Organization (CDSCO)
Developed ByCentre for Development of Advanced Computing (CDAC)
PortalSUGAM
Reporting Timeframes24 hours, 14 days, 30 days
Applicable RegionIndia

Frequently asked questions

What is a Serious Adverse Event (SAE)?

An SAE is any adverse drug event resulting in death, life-threatening condition, inpatient hospitalization or prolongation of hospitalization (>24 hours), persistent or significant incapacity, congenital anomaly/birth defect, or an important medical event requiring intervention to prevent serious outcomes.

What are the reporting timeframes for SAEs in India?

Investigators must report SAEs to CDSCO, sponsor, and ethics committee within 24 hours, and submit due analysis within 14 days. Sponsors must report to CDSCO, head of institution, and ethics committee within 14 days. Ethics committees must forward their report within 30 days of receiving the investigator's report.

Who must report SAEs on the SUGAM portal?

Site Principal Investigators who confirm SAEs occurred in their trial must report to CDSCO, their trial sponsor, and ethics committees. Sponsors and ethics committees also have reporting obligations through the portal.

Download PDF (4.5 MB)